Point and counterpoint: Polatuzumab vedotin in the front-line therapy for diffuse large B- cell lymphoma

Affiliations

Colin Thomas: Department of Medical Oncology, Sidney Kimmel Cancer Center at Thomas Jefferson University Hospital, Philadelphia, PA, United States
Sameep Thapa: Department of Internal Medicine, Thomas Jefferson University Hospital, Philadelphia, PA, United States
Connor McLaughlin: Department of Internal Medicine, Thomas Jefferson University Hospital, Philadelphia, PA, United States
Molly Halloran: Department of Medical Oncology, Sidney Kimmel Cancer Center at Thomas Jefferson University Hospital, Philadelphia, PA, United States
Pierluigi Porcu: Department of Medical Oncology, Sidney Kimmel Cancer Center at Thomas Jefferson University Hospital, Philadelphia, PA, United States

Abstract

No abstracts available.

ISSN: 2234-943X (Online)
Publisher: Frontiers Media S.A.
Country of publisher: Switzerland
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://www.frontiersin.org/journals/oncology/